Heart Diseases Clinical Trials in Phoenix, Arizona

5 studies are recruiting for heart diseases in Phoenix, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Transition to KPL-387 Monotherapy Dosing & Administration Study

    The primary objective of this study is to characterize the efficacy and safety of dosing regimens used to transition from prior pericarditis therapies to KPL-387 monotherapy in participants with well-controlled recurrent pericarditis on standard therapies.

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Investigational Site 031, Phoenix, Arizona
    Locations
    41 in total
    Run by
    Kiniksa Pharmaceuticals International, plc
  2. Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women

    The purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.

    Stage
    Phase 2
    Ages
    24 to 65
    Site
    Arizona State University, Phoenix, Arizona
    Run by
    Arizona State University
  3. Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

    The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Banner-University Medical Center Phoenix, Phoenix, Arizona
    Locations
    68 in total
    Run by
    Abbott Medical Devices
  4. American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)

    Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. …

    Stage
    Not phased
    Ages
    21 to 80
    Site
    NIDDK-Phoenix Epidemiology and Clinical Research, Phoenix, Arizona
    Locations
    3 in total
    Run by
    University of New Mexico
  5. The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

    The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Banner Health - Phoenix, Phoenix, Arizona
    Locations
    92 in total
    Run by
    Cardiac Dimensions, Inc.

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.